Common bone drugs may cut colon cancer risk
February 16th, 2011 - 1:39 pm ICT by ANIWashington, Feb 16 (ANI): Scientists have found that the use of bisphosphonates - drugs already taken by millions of healthy women to prevent bone-loss - for more than one year is associated with a 50 percent reduction in the risk of postmenopausal colorectal cancer.
Lead researcher Prof. Gad Rennert, of the Technion-Israel Institute of Technology Faculty of Medicine, says these findings further support the role of bisphosphonates as a possible new drug class for cancer prevention.
Rennert and colleagues extracted data from the Molecular Epidemiology of Colorectal Cancer (MECC) study, a population-based case-control study in northern Israel, conducted together with senior author Stephen Gruber, of the University of Michigan, Ann Arbor.
Using pharmacy records, the team evaluated the use of bisphosphonates in 1,866 postmenopausal female participants.
The researchers found that the use of bisphosphonates prior to diagnosis was strongly associated with a significant reduced relative risk for colorectal cancer.
The result remain the same even after making adjustments for a large variety of known risk or protective factors for colorectal cancer such as family history, dietary components, physical activity, body mass index, and the use of other medications such as aspirin, statins and hormone replacement therapy.
The results were published this week in the Journal of Clinical Oncology. (ANI)
- Statin use may cut risk of colorectal cancer - Oct 19, 2010
- Why statins work for some people, but not for all - Apr 22, 2010
- 'Statins prevent cancer in heart transplant patients' - May 20, 2012
- Long-term statin 'unlikely to increase cancer risk' - Nov 10, 2010
- Daily aspirin cuts bowel cancer death risk - Apr 26, 2012
- An aspirin a day 'cuts cancer death rate by 50pc' - Dec 07, 2010
- Bone loss drugs may cut breast cancer risk - Mar 03, 2010
- Osteoporosis drug 'doubles cancer risk' - Sep 03, 2010
- Aspirin may cut the risk of pancreatic cancer - Apr 05, 2011
- Study examines aspirin's ability to protect against colorectal cancer - Mar 10, 2011
- Aspirin reduces risk of cancer recurrence in prostate cancer patients - May 03, 2011
- Now, 'Trojan Horse' delivery system to attack cancer cells from inside - Jul 28, 2010
- Study: Aspirin cuts cancer risk by 20% - Dec 08, 2010
- New polypill halves heart disease and stroke risk - May 26, 2011
- Statins 'may prevent re-growth of prostate cancer' - Jun 28, 2010
Tags: bisphosphonates, body mass index, cancer prevention, case control study, colon cancer, colon cancer risk, colorectal cancer, dietary components, faculty of medicine, female participants, hormone replacement therapy, israel institute, michigan ann arbor, molecular epidemiology, northern israel, pharmacy records, relative risk, rennert, technion israel institute of technology, university of michigan ann arbor